Key Segmentation
By Dosage
-
High-dose Rate (HDR) Brachytherapy
-
Low-dose Rate (LDR) Brachytherapy
By Product
-
Seeds
-
Applicators & Afterloaders
-
Electronic Brachytherapy
By Application
-
Prostate Cancer
-
Gynecological Cancer
-
Breast Cancer
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
The Brachytherapy Market is expected to grow at a CAGR of 7.23% from 2026 to 2035.
The Brachytherapy Market was valued at USD 1,092 Million in 2025.
The Prostate Cancer segment dominated with approximately 33.15% share in 2025.
North America dominated the Brachytherapy Market with approximately 46.60% revenue share in 2025.
Rising global cancer burden, increasing adoption of HDR brachytherapy in outpatient settings, and technological advances in delivery systems and treatment planning are the primary growth factors.